UY32052A - 5-aminopirazoles sustituidos y uso de los mismos - Google Patents

5-aminopirazoles sustituidos y uso de los mismos

Info

Publication number
UY32052A
UY32052A UY0001032052A UY32052A UY32052A UY 32052 A UY32052 A UY 32052A UY 0001032052 A UY0001032052 A UY 0001032052A UY 32052 A UY32052 A UY 32052A UY 32052 A UY32052 A UY 32052A
Authority
UY
Uruguay
Prior art keywords
aminopirazols
replaced
same
prophylaxis
diseases
Prior art date
Application number
UY0001032052A
Other languages
English (en)
Inventor
Raimund Dr Kast
Peters Dr Kolkhof
Lars Dr Barfacker
Barbara Dr Albretch-Kuepper
Nitsche Adam
Heinrich Dr Meier
Griebenow Dr Nils
Stasch Dr Johannes-Peter
Schneider Dirk
Teusch Dr Nicole
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of UY32052A publication Critical patent/UY32052A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Abstract

La presente solicitud se refiere a 5-aminopirazoles sustituidos novedosos, a los procedimientos de producción de los mismos, al uso de los mismos, al uso de los mismos solos o en combinaciones para el tratamiento y/o profilaxis de enfermedades y uso de los mismos para la producción de productos medicinales para el tratamiento y/o profilaxis de enfermedades.
UY0001032052A 2008-08-21 2009-08-14 5-aminopirazoles sustituidos y uso de los mismos UY32052A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102008039083A DE102008039083A1 (de) 2008-08-21 2008-08-21 Substituierte 5-Aminopyrazole und ihre Verwendung

Publications (1)

Publication Number Publication Date
UY32052A true UY32052A (es) 2010-03-26

Family

ID=41100577

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032052A UY32052A (es) 2008-08-21 2009-08-14 5-aminopirazoles sustituidos y uso de los mismos

Country Status (11)

Country Link
US (1) US20100099681A1 (es)
EP (1) EP2321296A1 (es)
JP (1) JP2012500236A (es)
KR (1) KR20110042082A (es)
CN (1) CN102197031A (es)
AR (1) AR073064A1 (es)
CA (1) CA2734787A1 (es)
DE (1) DE102008039083A1 (es)
TW (1) TW201022225A (es)
UY (1) UY32052A (es)
WO (1) WO2010020363A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2871179A4 (en) 2012-07-03 2016-03-16 Ono Pharmaceutical Co CONNECTION WITH AGONISTIC EFFECT ON THE SOMATOSTATIN RECEPTOR AND ITS USE FOR MEDICAL PURPOSES
WO2014130241A1 (en) 2013-02-20 2014-08-28 E. I. Du Pont De Nemours And Company Fungicidal pyrazoles
WO2016092559A1 (en) * 2014-12-12 2016-06-16 Oat & Iil India Laboratories Private Limited Substituted pyrazole derivatives having activity as fungicides
WO2018052838A1 (en) 2016-09-16 2018-03-22 E. I. Du Pont De Nemours And Company Fungicidal pyrazoles
CN109890809A (zh) 2016-11-08 2019-06-14 默克专利股份公司 作为pfkfb的抑制剂的取代的喹喔啉衍生物
EP3354645A1 (en) * 2017-01-26 2018-08-01 Patheon Austria GmbH & Co KG Process for preparing urolithins
RU2020128799A (ru) 2018-02-27 2022-03-28 Амазентис Са Промышленный синтез уролитина а
TW202400547A (zh) 2018-09-06 2024-01-01 美商富曼西公司 殺真菌之經硝苯胺基取代之吡唑
CA3137152A1 (en) 2019-04-18 2020-10-22 The Johns Hopkins University Substituted 2-amino-pyrazolyl-[1,2,4]triazolo[1,5a] pyridine derivatives and use thereof
TW202200012A (zh) 2020-03-11 2022-01-01 美商富曼西公司 殺真菌劑混合物
CN113372200B (zh) * 2021-07-12 2022-04-19 无锡双启科技有限公司 一种2-溴-6-氟苯甲醚的制备方法
CN114773333A (zh) * 2021-12-25 2022-07-22 上海泰坦科技股份有限公司 一种卤代***并吡啶的合成方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5201938A (en) 1991-07-19 1993-04-13 Dowelanco N-pyrazolyl-1,2,4-triazolo[1,5-c]pyrimidine-2-sulfonamide herbicides
HUT69739A (en) 1992-03-26 1995-09-28 Dowelanco Process for producing n-heterocyclic nitroanilines and fungicides containing the compounds
US5541213A (en) * 1993-06-24 1996-07-30 Eisai Co., Ltd. Propenoic acid derivatives diazole propenoic acid compounds which have useful pharmaceutical utility
JPH07285962A (ja) 1994-04-20 1995-10-31 Nissan Chem Ind Ltd ピリジンカルボン酸アミド誘導体
DE19834047A1 (de) 1998-07-29 2000-02-03 Bayer Ag Substituierte Pyrazolderivate
DE19834044A1 (de) 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
DE19943634A1 (de) 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943636A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943635A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943639A1 (de) 1999-09-13 2001-03-15 Bayer Ag Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
AR031176A1 (es) 2000-11-22 2003-09-10 Bayer Ag Nuevos derivados de pirazolpiridina sustituidos con piridina
DE10110749A1 (de) 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
DE10110750A1 (de) 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE10220570A1 (de) 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine
UY27967A1 (es) 2002-09-10 2004-05-31 Pfizer Acetil 2-hindroxi-1,3-diaminoalcanos
AR042067A1 (es) 2002-11-27 2005-06-08 Bayer Pharmaceuticals Corp Derivados de anilinopirazol utiles en el tratamiento de la diabetes
US7022710B2 (en) * 2003-07-22 2006-04-04 Cv Therapeutics, Inc. A1 adenosine receptor antagonists
AR049418A1 (es) 2004-02-27 2006-08-02 Bayer Pharmaceuticals Corp Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes.
JP2007538102A (ja) 2004-05-20 2007-12-27 バイエル・フアーマシユーチカルズ・コーポレーシヨン 糖尿病の処置に有用な５−アニリノ−４−ヘテロアリールピラゾール誘導体
KR20070027584A (ko) 2004-06-17 2007-03-09 와이어쓰 고나도트로핀 방출 호르몬 수용체 길항제
EP1928455A1 (en) 2005-08-31 2008-06-11 Bayer Healthcare, LLC Anilinopyrazole derivatives useful for the treatment of diabetes
JP2009542809A (ja) 2006-07-12 2009-12-03 メルク エンド カムパニー インコーポレーテッド グレリン受容体アンタゴニストとしての置換ピラゾール
JP2010500372A (ja) 2006-08-09 2010-01-07 スミスクライン ビーチャム コーポレーション オピオイド受容体に対するアンタゴニストまたはインバースアゴニストとしての新規化合物

Also Published As

Publication number Publication date
CA2734787A1 (en) 2010-02-25
DE102008039083A1 (de) 2010-02-25
WO2010020363A1 (en) 2010-02-25
EP2321296A1 (en) 2011-05-18
AR073064A1 (es) 2010-10-13
CN102197031A (zh) 2011-09-21
TW201022225A (en) 2010-06-16
JP2012500236A (ja) 2012-01-05
US20100099681A1 (en) 2010-04-22
KR20110042082A (ko) 2011-04-22

Similar Documents

Publication Publication Date Title
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
DOP2014000255A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
HN2011002406A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
GT201400033A (es) Pirimidinas anilladas sustituidas y uso de las mismas
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
UY31228A1 (es) Ariloxazoles sustituidos y su uso
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
CR20110407A (es) Dicianopiridinas alquilamino-sustituidas y sus profármacos de éster de aminoácido
CR11684A (es) Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa
UY35693A (es) Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
CR20110318A (es) Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos
CR20110210A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales
DOP2009000285A (es) (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulacion sanguinea.
SV2009002953A (es) Nuevos derivados de furopirimidina aciclicos sustituidos y su uso
SV2010003773A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
BR112013020359B8 (pt) Colágeno gelificável e meios para a sua provisão
CU23704B7 (es) Nuevos derivados de furopirimidina acíclicos sustituidos y su uso
CU20100260A7 (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
HN2008000946A (es) Nuevos derivados de furopirimidina aciclicos sustituidos
NI201200162A (es) Inhibidores de pirazolil quinoxalina cinasa

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181112